In: Current Oncology Reports, 2021, vol. 23, no. 3, p. 10
Purpose of Review Richter syndrome (RS) is an uncommon but aggressive evolution of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). RS is an unmet clinical need in the field of CLL. Recent advances in understanding the biology of this condition provide the rationale for testing new therapeutic concepts in order to improve the outcome of patients developing RS, which is so far...
|
In: European Journal of Epidemiology, 2015, vol. 30, no. 12, p. 1287-1298
|
In: Annals of Hematology, 2015, vol. 94, p. 177-186
|
In: Quality of Life Research, 2015, vol. 24, no. 9, p. 2151-2161
|
In: The American Journal of Clinical Nutrition, 2018, vol. 107, no. 1, p. 3-11
|
In: European Journal of Epidemiology, 2015, vol. 30, no. 12, p. 1263-1275
|
In: International Immunology, 2017, vol. 29, no. 9, p. 423-429
|
In: Journal of Perinatal Medicine, 2017, vol. 45, no. 7, p. 829-835
|
In: Leukemia, 2021, p. 7 p
The prognostic significance of lymphocyte doubling time (LDT) in chronic lymphocytic leukemia (CLL) was identified when the biology of the disease was poorly understood and therapy was not effective. We assessed the clinical and biological significance of LDT in 848 CLL patients in a real-life setting and the context of new biomarkers and effective therapy. A short LDT (≤12 months) was...
|
In: Blood, 2020, vol. 137, no. 10, p. 1365–1376
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (quasi)identical, stereotyped B cell receptor immunoglobulins (BcR IG). Patients in certain major stereotyped subsets often display remarkably consistent clinicobiological profiles, suggesting that the study of BcR IG stereotypy in CLL has important implications for understanding disease...
|